Source: BioPortfolio

Gen9: Gen9 Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryGen9 Inc Gen9 is a gene synthesis company that specializes in the manufacturing of synthetic DNA. The company uses BioFab technology a chipbased manufacturing platform to build synthetic DNA constructs which are used by scientists to construct pathw...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kevin Munnelly's photo - President & CEO of Gen9

President & CEO

Kevin Munnelly

CEO Approval Rating

63/100

Read more